Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

News from ASRM/CFAS '99: Hughes Institute hones in on anti-HIV spermicides

Oct. 27, 1999

Tenofovir disoproxil fumarate: clinical activity correlated with intracellular levels

Oct. 27, 1999

Coactinon effective and safe as part of first-line protease inhibitor-sparing regimen

Oct. 27, 1999

Agouron to commercialize Rescriptor throughout the world; anti-HIV pipeline grows

Oct. 26, 1999

Anti-HIV pseudopeptide has a unique mechanism of action

Oct. 22, 1999

Licensing opportunity from NIH: aspartic HIV protease inhibitors

Oct. 21, 1999

Advantageous pharmacokinetic profile reported for HI-240 in mice

Oct. 20, 1999

Multikine may reduce opportunistic infections in patients with HIV

Oct. 20, 1999

Antiviral advisory committee meets in early November to discuss NDA for anti-HIV drug

Oct. 18, 1999

Clinical trials of lodenosine suspended pending review of safety data

Oct. 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.